Related Experiment Videos
[Therapy of meningitis (author's transl)]
Abstract:
For the specific and unspecific treatment of purulent meningitis, penicillin, ampicillin and chloramphenicol are usually sufficient. Only resistant pathogens (Klebsiella, Pseudomonas among others) and meningitis in infants require other treatment. Cephalosporins and aminoglycosides only come into consideration for the treatment of very rare exceptional cases. The still relatively poor prognosis of purulent meningitis is largely independent of the efficacy of the treatment. Delay in beginning therapy, lack of intensive care, primary diseases and complications are principally responsible for this. Medicamentous prophylaxis is only possible for meningococcal meningitis. The distribution of antibiotics in the CSF is irregular. Also the antibacterial activity in the CSF is different from culture media.
Insights
Penicillin, ampicillin, and chloramphenicol effectively treat most purulent meningitis cases. Poor prognosis stems from treatment delays and complications, not solely antibiotic efficacy.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Context:
- Purulent meningitis treatment guidelines.
- Antibiotic resistance patterns.
- Cerebrospinal fluid (CSF) penetration and activity.
Purpose:
- To review current antibiotic strategies for purulent meningitis.
- To discuss factors influencing treatment outcomes.
- To highlight limitations in antibiotic prophylaxis and CSF penetration.
Summary:
- Penicillin, ampicillin, and chloramphenicol are standard treatments for purulent meningitis, effective against most common pathogens.
- Resistant strains (e.g., Klebsiella, Pseudomonas) and infant meningitis necessitate alternative therapies, with cephalosporins and aminoglycosides reserved for rare cases.
- Prognosis is primarily linked to delayed therapy, intensive care availability, and complications, rather than solely antibiotic efficacy. Antibiotic distribution and activity in CSF are variable and differ from culture media.
Impact:
- Informs clinical decision-making for purulent meningitis management.
- Highlights the importance of early diagnosis and supportive care.
- Underscores the need for ongoing research into antibiotic efficacy and resistance in CNS infections.